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ABSTRACT 
 
Chromium is widely used in medical and dental implants, appliances and tools, where sufficient 
content s of this chemical element can provide a protective corrosion-resistant oxide on the alloy 
surface. At low concentrations chromium is used for medical purposes, and it is also involved in 
natural human lipid and protein metabolism. However, at sufficiently high concentrations 
particularly hexavalent chromium is toxic and carcinogenic. The healthy risks can be expected 
regardless whether the chromium originates from external sources such as polluted drinking water 
or internally from corroding dental appliances. As the latter source is likely to provide chromium 
exposure only at low to modest concentrations, no acute effects are generally expected. The 
current paper aimed to briefly review the toxicology aspects of chromium in general and in oral 
exposure from applications, used in dentistry. It was concluded that most likely oral effects are 
chronic, including carcinogenic impact, but more studies are directed to investigation on the chronic 
effects of chromium release from dental appliances. 
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1. INTRODUCTION 
 
Chromium (Cr) is a silvery white transition metal 
with atomic number of 24, relative atomic mass 
of 52.996 g/mol, and price between iron and 
nickel [1]. Inherent brittleness sets the upper limit 
for its content in commercial alloys mostly to 
below 30-40% by weight. In medical and                    
dental applications as tools, implants,                         
bridges and other metallic appliances,                   
chromium is a common alloying component.                  
The main benefit of this chemical                         
element in these alloys is the inert protective 
oxide that forms on the surfaces in suitably 
oxidizing environments. For full surface     
coverage by chromium oxide (Cr2O3), more than 
10% of Cr is required, and typically the range of 
Cr content is 15 - 28%, for example in stainless 
steels.   
 
At low concentrations, Cr is involved in natural 
human lipid and protein metabolism, so that very 
small amounts are needed for normal human life 
functions [2]. Much of the daily intake of 
chromium, typically about 100 µg, is from foods 
such as grains, fruits and vegetables, potatoes, 
seafood, mushrooms and egg yolk [2,3]. In 
addition, low to modest amounts of chromium 
can appear in other potential sources such as 
type II anti-diabetic and dietary drugs [2,3]. 
Chromium also occurs at much higher 
concentrations in industrial processes that can 
release potential pollutants to air and drinking 
water [2].  
 
In dentistry, a variety of chromium-containing 
alloys can be found in most prosthodontic 
devices, orthodontic appliances, restorative 
devices, and in alloys and coatings of standard 
tools used by dentists [1]. Many of these devices 
are directly exposed to the oral cavity 
environment for a prolonged time, maybe years 
to decades. The natural host-alloy surface 
interaction will release metal ions to contact oral 
cells, and become ingested [4]. Metallic ions 
have been shown to occur at elevated 
concentrations in saliva of dental patients using 
prosthodontic devices [4,5,6]. 
 
The main attention of the present paper is in 
chromium ions that can leach out from gradually 
corroding dental alloys under the influence of 
human body liquids such as saliva, resulting in 
potentially significant human exposure. The oral 
environment can promote metal corrosion due to 
its temporally variable pH conditions, and other 
factors such as bacterial activity, various foods, 
drugs or supplements can also change the 
balance of oral condition to affect ion release. 
[5,6].  
 
Chromium ions in solution occur in two common 
forms, relatively safer Cr (III) and more toxic Cr 
(VI), and particularly the latter is not similarly 
biocompatible as solid chromium oxide in human 
contact [1-6]. In principle chromium therefore 
represents a potential health risk also when used 
in dentistry. Some chromium containing alloys for 
dental applications are shown in Table 1. 
 
Table 1. Alloys with chromium in dental applications 
 
Alloy type Dental use Metal elements 
Co-Cr alloys Restorations  Co, Cr, Mo, Fe, Mn 
Ni alloys, Ni-Ti Restorations, orthodontic appliances Ni, Mo, Fe, Be, Mn, Cr 
Stainless steels Implants, orthodontic appliances, tools Cr, Fe, Ni, Mn, Mo  
 
Every metal has a characteristic reduction potential to describe its galvanic reactivity. Towards the left 
end of this galvanic series (shown below) the metal becomes more easily oxidized, and is more easily 
releasing metal ions particularly in an acidic environment [6,7]. 
 
Be, Ti, Mn, Zn, Cr, Ga, Fe, In, Co, Ni, Mo, Sn, H2, Cu, Hg, Ag, Pd, Pt, Au 
 
                  Oxidation           Reduction 
 
In this series chromium is a relatively reactive metal, i.e. easily available for chemical reactions if the 
metal surface is not fully protected by the oxide. At least partial loss of protection can be expected for 
example from the influence of heat, low pH, tooth brushing, mastication (repeated mechanical loading) 
and aging of dental appliances, to result in release of chromium to the oral environment [8,9].  
 
Some release of chromium ions is known to be related by the interaction of chromium in dental 
devices with saliva, acids, and bacteria [8]. In stainless steel dental implants, ion release may cause 
high microscopic dental porosity in artificial saliva, with increased pore density in saliva containing 
fluoride [9,10]. 
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In general, the release of metal ions to the saliva 
may be slight, but it is accelerated in acidic pH, 
and release of chromium has been reported from 
dental devices made by casting, milling, and 
sintering, on average 0.8-0.9 mg/L in saliva per 
month [8]. The released amount can increase by 
exposure to strong oxidizing agents such as 
fluoride application and acidic products from oral 
bacteria [8,9,10]. 
 
Chromium ions in saliva will be ingested and 
reach the gastrointestinal tract that can reduce 
most Cr (VI) to Cr (III), especially post meal 
[11,12,13]. At the gastrointestinal tract, the Cr (III) 
ions will be slightly absorbed depending on the 
form of its chemistry and transit time [14]. When 
the rest of Cr (VI) ions have been absorbed into 
the vascular tract, they will be easily infiltrated to 
red blood cells and become reduced to Cr (III) 
ions [14]. Some Cr (III) ions will bind to 
transferrin in blood plasma and circulate 
throughout the body [14]. Furthermore, about of 
60% Cr (VI) ions and 10% of Cr (III) ions will be 
excreted through the kidneys, and small amonts 
through hair, nails, milk, and sweat [14].  
 
In the body metabolism pathway, chromium ions 
can bind to proteins to form complex proteins 
[14]. Chromium ions can also be detected in 
bone marrow, lungs, lymph nodes, spleen, 
kidneys, and liver, with the highest observed 
concentration in the lung cells [14]. Cr (III) ions 
have been shown to bind to nucleic acids very 
strongly, and may keep RNA from heat-induced 
denaturation [15]. 
 
2. HEALTH HAZARDS OF CHROMIUM, 
RELATED MECHANISMS AND 
PATHWAYS 
 
Human exposure to sufficiently high chromium 
concentrations would result in potential harm 
through its toxic, genotoxic and carcinogenic 
effects [1,12,16-19]. Chromium is one of eight 
metals in the top 50 toxic substances in the world 
in the data issued by the Agency for Toxic 
Substances and Disease Registry (ATSDR), and 
WHO has classified chromium as carcinogenic to 
human beings [8,11,20,21]. 
 
Under normal circumstances (Table 2), the 
majority of chromium ions appear as trivalent Cr 
(III) or hexavalent Cr (VI) [1-19,22-24]. An 
important distinction is that most of Cr (III) will be 
excreted in urine, while most of Cr (VI) will 
remain in the body [20]. 
 
Cr (VI) ions are strongly oxidizing, and of all Cr 
ions most toxic and with highest risk to trigger 
carcinogenesis [1,15,18,19]. Under suitable 
conditions Cr (III) can be oxidized to Cr (VI) by 
the reaction 2Cr2O3 + 3O2 → 4CrO3, to increase 
the toxic impact of chromium exposure [15,18,19]. 
 
Cr (VI) is more easily absorbed into the human 
body than Cr (III) because the active form of Cr 
(VI) as chromate resembles structurally sulphate 
and therefore easily penetrates cell membranes, 
including those of red blood cells, by sulphate 
transporters [17,20,25]. Many quantitative 
studies have shown that ion forms of chromium 
have higher absorption than its less soluble 
forms, such as chromium in the form of diabetic 
dietary supplements [14]. The lower is the oral 
daily intake, the higher will be the gastrointestinal 
chromium absorption rate [14].  
 
After absorption, Cr (VI) can be reduced back to 
Cr (III) but this reduction takes place at the cost 
of inflicted cellular damage. In the metabolic 
processes of chromium it can induce oxidative 
stress with glutathione (GS*) radical to oxidize 
the surrounding environment, with the potential 
to attack adenine and guanine in DNA and to 
produce DNA adducts [15,26]. With DNA damage 
and/or incomplete DNA repair, this can lead to 
carcinogenesis [26]. The oxidation and reduction 
processes of chromium are outlined in Fig. 1. 
 
Chromium ions can react with reducing agents 
such as H2O, Mn(II), NO2, Fe(II), S2–, and CH4 
and oxidizing agents such as O2 (aq), O3 (aq), 
Mn(IV), NO3, Fe(III), SO2–, and CO2 to produce 
free radicals.15 Cr (III) can also be oxidized by 
materials such as mouthwash, toothpaste and 
prophylactic gels containing fluorides, povidone 
iodine and endodontic chemicals [1]. Cr (III) can 
therefore become more toxic Cr (VI) when 
subjected to such oxidizing agents in the oral 
environment. 
 
Table 2. Occurrence and characteristics of Cr(III) and Cr(VI) [18] 
 
Cr(III), trivalent chromium  Cr(VI), hexavalent chromium 
[Cr(H2O)6]3+ [(H2O)5Cr(OH)]2+, Cr(OH)3 
More stable in alkaline conditions 
Less toxic, used as a supplement 
CrO42−, Cr2O72− H2CrO4, HCrO4− 
More stable in acidic conditions 
Genotoxic and carcinogenic, strong oxidant 
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Fig. 1. Reduction and oxidation reactions of chromium ions [26] 
 
 
 
Fig. 2. Reduction and oxidation reactions of chromium ions from anti-diabetic drugs to trigger 
genotoxicity [27] 
 
Chromium ions originating from antidiabetic 
drugs can be reduced and oxidized with certain 
metabolic pathways shown in Fig. 2 above.  
 
In particular, Cr (III) from these drugs                    
can be oxidized in the gastrointestinal medium, 
blood plasma, and other extracellular fluids into 
protein complexes and then ionized with DNA 
resulting in DNA adducts [27]. Therefore 
chromium-containing anti-diabetic drugs can 
potentially have genotoxic and carcinogenic 
effects. 
 
In general human exposure to chromium is 
mainly through inhalation, ingestion or skin 
contact [20].  
 
Chromium absorption through inhalation has 
been demonstrated by subsequent increase in 
the Cr levels in urine [27-29].  
In case of oral exposure and ingestion, Cr (VI) is 
in most cases absorbed by gastrointestinal 
mucosa better than Cr (III) [30]. Stainless steel 
brackets and nitinol wires in orthodontic 
appliances are known to release chromium ions, 
with 33.5 ppb Cr reported from saliva initially and 
17.9 ppb after 10-12 months of use; three times 
more chromium ions than nickel ions were 
released [31]. 
 
Occupational studies have indicated that Cr (VI) 
can be absorbed through the skin [29]. In 
contrast, Cr (III) shows poor skin absorption in 
experimental animals [32]. 
 
3. EFFECTS AND SAFETY LIMITS OF 
CHROMIUM EXPOSURE  
 
The effects of chromium exposure on health 
would depend on dose and organ at risk, and the 
  
 
 
Achmad et al.; ARRB, 13(2): 1-8, 2017; Article no.ARRB.33462 
 
 
 
5 
 
exposure is generally by a mixture of Cr (III) and 
Cr (VI) ions [20]. High concentrations that                 
cause acute effects are often related to pollution 
of the environment. Acute reaction will only occur 
at above the chromium LD 50 level (20–250 mg 
Cr (VI) and 185–615 mg Cr (III) per kg body 
weight) [11]. The Pacific Gas and Electric 
Company (PG&E) case in California is an 
example of many chromium pollution cases that 
caused both acute and chronic effects to the 
population.  
 
Existing and suggested limits to chromium 
exposure are listed in Table 3. The following 
health effects can be expected:   
 
 Respiratory challenges 
 
Depending on the dose, acute effects      
include irritation and obstruction of                      
airways, and chronic effects of pulmonary 
irritation due to exposure through                    
inhalation may occur as asthma, chronic 
bronchitis, chronic irritation, chronic 
pharyngitis, chronic rhinitis, congestion and 
hyperemia, polyps in the upper respiratory 
tract, tracheobronchitis, and ulceration of the 
mucous nasal membranes with the 
perforation possibility of the septum. 
[17,20,33]  
 
 Skin 
 
Chromium effects often occur in the form of 
irritation or dermatitis due to allergies. The 
dermatitis symptoms include dryness, 
erythema, fissured skin, papules, small 
vesicles, and swelling [17,20]. 
 
 Cancer  
 
Chromium-related cancer often occurs                       
in the respiratory system, mainly as lung, 
nasal and sinus cancers [20]. Reaction                        
of Cr (VI) with ascorbate (reductant)                         
and hydrogen peroxide (oxidizer) will result 
in the accumulation of hydroxyl radicals that 
cause DNA damage, mutations, and 
increasing cancer potential [17,19]. 
Alterations in DNA can be found as DNA 
strand breaks, Cr-DNA adducts, DNA-DNA 
and DNA-protein crosslinks, and oxidative 
DNA damage [16,21]. In addition, Cr (VI) has 
been reported to inhibit epigenetically (by 
methylation) the tumor suppressor gene 
p16Ink4A that is frequently altered in cancer. 
[34].  
 
 Other health effects 
 
Other symptoms may be more severe if the 
dose exceeds a threshold [20]:  
 
 Mild symptoms: dizziness, general 
weakness, eye irritation 
 Severe symptoms: kidney, liver, 
gastrointestinal, cardiac, hematologic or 
reproduction disorders, growth problems, 
nasal perforation, corneal injury  
 Abnormalities of teeth as discoloration 
and erosion, accompanied by high Cr 
concentration in tongue papillae. 
 
Table 3. Limits for Cr(III) and Cr(VI)  [19-21,24,34] 
 
Defined limit Cr(III), trivalent  Cr(VI), hexavalent  Sources 
LD50*  185-615 mg/kg bw 20-250 mg/kg WHO [8]  
Safe daily dose**  0.03-0.13 µg/kg bw/d** - WHO [8]  
Normal level 20-30 µg/l (blood),                     <10 µg/l (urine, 24 h) ATSDR [14] 
Limit, water*** 50 µg/l (total Cr) 0.02 µg/l WHO, OEHHA [34] 
Limit, air**** 0.5 mg Cr/m3 0.05 mg Cr/m3 ACGIH  [24] 
Limit, toys***** - 0.0002 µg/kg bw/d  SCHER [34] 
* oral exposure, per kg body weight, estimated acute effect from in vitro tests 
** per kg body weight per day, corresponding to 2-8 µg per day for a 60 kg person  
  *** for drinking water, public health goal (PHG) for Cr(VI) 
 **** for atmospheric exposure in 8 h-day or 40 h-week; for insoluble Cr(VI) 0.01 mg Cr/m3 
***** per kg body weight per day, corresponds to e.g. 0.0002 mg/kg liquid toy material released 
Abbreviations: WHO: World Health Organization; ATSDR: Agency for Toxic Substances and Disease Registry 
(US); OEHHA: Office of Environmental Health Hazard Assessment (California);  
ACGIH: American Conference of Governmental Industrial Hygienists (US);  
SCHER: Scientific Committee on Health and Environmental Risks (EU)  
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4. DISCUSSION 
 
As can be expected, recently suggested limits for 
chromium exposure tend to be stricter than in the 
past. This is partly due to accumulating 
information from research on the health risks of 
chromium, and partly because of the adopted 
principle to limit risks to lowest levels reasonably 
achievable, particularly for Cr (VI) exposure. The 
resulting suggested limits for example in case of 
drinking water are showing this development: 
while the recommended WHO (2003) limit for 
total chromium is 50 µg/l, the recent 
recommended OEHHA (2011) public health goal 
for Cr (VI) is 0.02 µg/l. The difference is quite 
large considering typical chromium levels in 
drinking water, and that common treatment of 
drinking water by ozone, chlorine and/or chlorine 
dioxide will oxidise any Cr(III) almost completely 
to Cr(VI) [35].  
 
The stated limits may reflect some thresholds for 
example between the naturally required intake of 
chromium and harmful levels indicated by 
toxicology studies. However, for Cr (VI) it is 
debatable whether real thresholds exist in case 
of carcinogenic impact. In such a case the 
adopted or recommended limit, or virtual safe 
dose, may be based on a level of additional risk, 
for example in terms of level of exposure for one 
additional cancer case per million comparable 
subjects at risk for life (70 years). The resulting 
recommended limit (in Table 3) for Cr (VI) in toys 
is more than an order of magnitude lower than 
the current legal (directive) limit in EU [35].  
 
For safe daily dose, WHO was set 2–8 µg Cr (III) 
per day, which is equivalent to 0.03 to 0.13 µg Cr 
(III) per kg of body weight per day for 60kg 
human adult [21]. These results are calculated 
using an estimate of 0.5-2 µg Cr (III) will be 
absorbed and deposited in the body, while the 
other 75% excreted out [21]. 
 
The level in red blood cells (RBC) in particular 
can indicate the exposure to Cr (VI) because of 
the selective properties of the RBC membrane 
[24].   
 
In dental applications, exposure of mucosal cells 
to chromium ions can correspond to about 0.9 
mg/L per month, or 30 µg/L per day [8]. With the 
assumption that the daily saliva secretion is 
about 1L per day, there will be only about 30 µg 
of chromium ions in the saliva to interact with the 
oral environment. This amount will be increased 
in acidic oral conditions due to poor oral hygiene, 
fluoride application, acidic food consumption, etc. 
If only 30 µg of chromium is released in good 
oral pH condition without any added acidic 
intervention, the amount will be between the safe 
limits according to ATSDR (20-45 µg chromium 
as supplement) [8,11]. Worse outcome is 
possible under conditions that trigger metal 
oxidation such as hot condition, low pH, 
mastication, or some dental treatment such as 
fluoridation and bleaching. 
 
Apart from the concentration of chromium ions, 
the time of interaction itself is a risk factor, as we 
know that  prolonged exposure to dental devices 
and their aging will worsen corrosion. The 
combination of  specific conditions may lead to 
the increase of chromium ions concentration in 
oral environment. 
 
After ingestion, the concentration of chromium 
ions will bedecreased by---- body metabolism. 
Chromium ions, especially Cr (VI), will be 
reduced in ingestion tract and blood, and some 
of it will get excreted via kidneys pathway that 
lead to concentration decrease in the body.  
 
At low chromium concentrations that do not 
cause acute effects, significant chronic effects 
can still occur and should be properly considered. 
This is likely to apply to chromium released from 
dental alloys, as it is expected to be initially 
mostly Cr (III) and even if partially converted to 
Cr (VI) in the oral environment, only occurring at 
low to modest concentrations. However, there is 
very little information on the chronic effects of 
this type of human exposure to chromium [36].  
 
Levels of human exposure to chromium can be 
reduced by provision of active absorbants, such 
as chitosan, activated carbon, a surfactant, or 
zeolite that can absorb Cr (VI) to mitigate the risk 
[19,23]. Dentists may need to consider their 
decisions to install chromium based dental 
applications depending on simultaneous use of 
fluorides, poor level of oral hygiene of the patient, 
and other factors which could induce greater 
chromium  release. 
 
5. CONCLUSION 
 
In summary, human exposure to chromium 
above safe concentration limits is a recognized 
risk for the health. Of its two common stable 
forms, trivalent Cr (III) is a required nutrient and 
carries low risk, while a significant health risk is 
associated with hexavalent Cr (VI) that is more 
easily transported through the cellular 
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membranes, which could lead to damage in lipids, 
proteins and DNA. Chromium, released from 
dental appliances, is likely to be initially mostly Cr 
(III), but if a part of it is converted to Cr (VI) in 
oral environment, the potential health risk from 
chromium exposure is of interest also in dentistry. 
As the concentration levels are likely to be 
generally below those causing acute effects, 
further studies on the possible chronic effects of 
chromium, released from dental alloys, are 
necessary.  
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